D-pinitol inhibits RANKL-induced osteoclastogenesis

International Immunopharmacology

Volumn 12, Issue 3, 2012, Pages 494-500

  Liu, Shan Chi ^a   Chuang, Show Mei ^a   Tang, Chih Hsin ^b,c  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Chinese herb; d pinitol; NF B; Osteoclasts

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CARBOXY TERMINAL TELOPEPTIDE; DEXTRO PINITOL; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL DERIVATIVE; LUCIFERASE; OSTEOPONTIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ATTENUATION; BONE DENSITY; BONE MARROW CELL; BONE MINERAL; CELL ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REPORTER GENE; STROMA CELL;

ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; BONE RESORPTION; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GROWTH INHIBITORS; INOSITOL; MACROPHAGES; MAP KINASE KINASE 4; NF-KAPPA B; OSTEOCLASTS; OSTEOGENESIS; OSTEOPOROSIS; OVARIECTOMY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RANK LIGAND; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; STROMAL CELLS; TRANSFECTION;

EID: 84862831503     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.01.002     Document Type: Article

References (26)

1. D. Goltzman Discoveries, drugs and skeletal disorders Nat Rev Drug Discov 1 2002 784 796 (Pubitemid 37361562)
2. G.A. Rodan, and T.J. Martin Therapeutic approaches to bone diseases Science 289 2000 1508 1514
3. S.L. Teitelbaum Bone resorption by osteoclasts Science 289 2000 1504 1508
4. N. Udagawa, N. Takahashi, T. Akatsu, H. Tanaka, T. Sasaki, and T. Nishihara Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells Proc Natl Acad Sci U S A 87 1990 7260 7264
5. G.Q. Yao, B. Sun, E.E. Hammond, E.N. Spencer, M.C. Horowitz, and K.L. Insogna The cell-surface form of colony-stimulating factor-1 is regulated by osteotropic agents and supports formation of multinucleated osteoclast-like cells J Biol Chem 273 1998 4119 4128 (Pubitemid 28103280)
6. B.G. Darnay, V. Haridas, J. Ni, P.A. Moore, and B.B. Aggarwal Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase J Biol Chem 273 1998 20551 20555 (Pubitemid 28377625)
7. S.Y. Lee, A. Reichlin, A. Santana, K.A. Sokol, M.C. Nussenzweig, and Y. Choi TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival Immunity 7 1997 703 713 (Pubitemid 28156637)
8. J.G. Streeter Carbohydrates in soybean nodules: II. Distribution of compounds in seedlings during the onset of nitrogen fixation Plant Physiol 66 1980 471 476
9. A. Numata, C. Takahashi, R. Fujiki, E. Kitano, A. Kitajima, and T. Takemura Plant constituents biologically active to insects. VI. Antifeedants for larvae of the yellow butterfly, Eurema hecabe mandarina, in Osmunda japonica. (2) Chem Pharm Bull (Tokyo) 38 1990 2862 2865 (Pubitemid 20386069)
10. R.K. Singh, B.L. Pandey, M. Tripathi, and V.B. Pandey Anti-inflammatory effect of (+)-pinitol Fitoterapia 72 2001 168 170 (Pubitemid 32153818)
11. P.K. Geethan, and P.S. Prince Antihyperlipidemic effect of D-pinitol on streptozotocin-induced diabetic Wistar rats J Biochem Mol Toxicol 22 2008 220 224
12. C.H. Tang, T.L. Hsu, W.W. Lin, M.Z. Lai, R.S. Yang, and S.L. Hsieh Attenuation of bone mass and increase of osteoclast formation in decoy receptor 3 transgenic mice J Biol Chem 282 2007 2346 2354
13. M.T. Hsieh, C.L. Hsieh, L.W. Lin, C.R. Wu, and G.S. Huang Differential gene expression of scopolamine-treated rat hippocampus-application of cDNA microarray technology Life Sci 73 2003 1007 1016 (Pubitemid 36734817)
14. S.H. Fang, Y.C. Hou, W.C. Chang, S.L. Hsiu, P.D. Chao, and B.L. Chiang Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock Life Sci 74 2003 743 756
15. Y.C. Wang, P.J. Lee, C.M. Shih, H.Y. Chen, C.C. Lee, and Y.Y. Chang Damage formation and repair efficiency in the p53 gene of cell lines and blood lymphocytes assayed by multiplex long quantitative polymerase chain reaction Anal Biochem 319 2003 206 215
16. K.W. Lu, J.C. Chen, T.Y. Lai, J.S. Yang, S.W. Weng, and Y.S. Ma Gypenosides causes DNA damage and inhibits expression of DNA repair genes of human oral cancer SAS cells In Vivo 24 2010 287 291
17. H.C. Huang, G.Y. Shi, S.J. Jiang, C.S. Shi, C.M. Wu, and H.Y. Yang Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain J Biol Chem 278 2003 46750 46759
18. C.P. Tseng, C.L. Huang, C.H. Huang, J.C. Cheng, A. Stern, and C.H. Tseng Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells FEBS Lett 541 2003 21 27 (Pubitemid 36428911)
19. D.Y. Lu, Y.M. Leung, S.M. Huang, and K.L. Wong Bradykinin-induced cell migration and COX-2 production mediated by the bradykinin B1 receptor in glioma cells J Cell Biochem 110 2010 141 150
20. H.Y. Tsai, H.Y. Lin, Y.C. Fong, J.B. Wu, Y.F. Chen, and M. Tsuzuki Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway Eur J Pharmacol 588 2008 124 133
21. J.M. Quinn, J. Elliott, M.T. Gillespie, and T.J. Martin A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro Endocrinology 139 1998 4424 4427 (Pubitemid 28513734)
22. H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, and S. Mochizuki Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc Natl Acad Sci U S A 95 1998 3597 3602
23. M.J. Bossard, T.A. Tomaszek, M.A. Levy, C.F. Ijames, M.J. Huddleston, and J. Briand Mechanism of inhibition of cathepsin K by potent, selective 1, 5-diacylcarbohydrazides: a new class of mechanism-based inhibitors of thiol proteases Biochemistry 38 1999 15893 15902 (Pubitemid 129520482)
24. N.A. Hamdy Targeting the RANK/RANKL/OPG signaling pathway: a novel approach in the management of osteoporosis Curr Opin Investig Drugs 8 2007 299 303 (Pubitemid 46557990)
25. C. Berg, K. Neumeyer, and P. Kirkpatrick Teriparatide Nat Rev Drug Discov 2 2003 257 258
26. P. Ducy, T. Schinke, and G. Karsenty The osteoblast: a sophisticated fibroblast under central surveillance Science 289 2000 1501 1504